Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
The duration can vary based on the specific treatment and nutrient formulation being administered
Lillys Mounjaro (tirzepatide), a GIP/GLP-1 dual agonist, demonstrated cardiovascular protection in landmark head-to-head trial, reinforcing its benefit in patients with type 2 diabetes and heart disease
Tirzepatide burns stored fat in the body for energy production while stabilizing blood glucose levels
These medications improve insulin resistance and related metabolic conditions, are increasingly used to support patients with autoimmune disease, reduce the risk of certain cardiovascular and neurologic conditions, and help manage chronic inflammation
US$ 28.65
US$ 26.75
US$ 26.28
US$ 27.76
US$ 29.03
